Allworth Financial LP

Position in ANAB — Anaptysbio, Inc

CIK 1555170 FOLSOM, CA

Position in ANAB

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$10,125

+$1,585 QoQ

Shares Held

150

-35.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#186

of 211 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $18,605,644 across 285 Biotechnology names. ANAB ranks #128 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	37,664	$2,947,961
2	VRTX	Vertex Pharmaceuticals Inc / Ma	4,487	$2,228,827
3	MDGL	Madrigal Pharmaceuticals, Inc.	3,562	$1,912,615
4	REGN	Regeneron Pharmaceuticals, Inc.	2,530	$1,577,556
5	INCY	Incyte Corp	5,182	$587,431
6	EXEL	Exelixis, Inc.	10,562	$574,678
7	CRSP	CRISPR Therapeutics AG	10,089	$550,254
8	RVMD	Revolution Medicines, Inc.	2,240	$419,507

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,125	150	-2.6%	Shares	Sole	2026-08-11
2026-03-31	$8,540	154	+7.7%	Shares	Sole	2026-05-15
2025-12-31	$6,932	143	-78.7%	Shares	Sole	2026-02-05
2025-09-30	$20,545	671	-0.9%	Shares	Sole	2025-12-02
2025-06-30	$15,029	677	-1.5%	Shares	Sole	2025-08-07
2025-03-31	$12,771	687	+780.8%	Shares	Sole	2025-04-30
2023-09-30	$1,400	78	0.0%	Shares	Sole	2023-10-31
2023-06-30	$1,586	78	0.0%	Shares	Sole	2023-07-18
2023-03-31	$1,697	78	0.0%	Shares	Sole	2023-04-18
2022-12-31	$2,417	78	0.0%	Shares	Sole	2023-01-13
2022-09-30	$1,989	78	0.0%	Shares	Sole	2022-11-14
2022-06-30	$1,583	78	0.0%	Shares	Sole	2022-07-13
2022-03-31	$1,929	78	0.0%	Shares	Sole	2022-04-22
2021-12-31	$2,710	78	0.0%	Shares	Sole	2022-01-21
2021-09-30	$2,115	78	0.0%	Shares	Sole	2021-11-02
2021-06-30	$2,022	78	0.0%	Shares	Sole	2021-08-02
2021-03-31	$1,680	78	—	Shares	Sole	2021-04-29
No filing history on record for this holder in this stock.